Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: A phase
            III
            randomized, double‐blind, placebo‐controlled trial

Victor Biton; Samuel F. Berkovic; Bassel Abou‐Khalil; Michael R. Sperling; Martin E. Johnson; Sarah Lu

doi:10.1111/epi.12433

Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: A phase III randomized, double‐blind, placebo‐controlled trial

Epilepsia ◽

10.1111/epi.12433 ◽

2013 ◽

Vol 55 (1) ◽

pp. 57-66 ◽

Cited By ~ 138

Author(s):

Victor Biton ◽

Samuel F. Berkovic ◽

Bassel Abou‐Khalil ◽

Michael R. Sperling ◽

Martin E. Johnson ◽

...

Keyword(s):

Controlled Trial ◽

Partial Epilepsy ◽

Phase Iii ◽

Adjunctive Treatment ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Adjunctive zonisamide therapy in the long-term treatment of children with partial epilepsy: Results of an open-label extension study of a phase III, randomized, double-blind, placebo-controlled trial

Epilepsia ◽

10.1111/epi.12548 ◽

2014 ◽

Vol 55 (4) ◽

pp. 568-578 ◽

Cited By ~ 24

Author(s):

Renzo Guerrini ◽

Anna Rosati ◽

Kate Bradshaw ◽

Luigi Giorgi

Keyword(s):

Controlled Trial ◽

Term Treatment ◽

Partial Epilepsy ◽

Phase Iii ◽

Open Label ◽

Double Blind ◽

Double Blind Placebo ◽

Long Term Treatment ◽

Open Label Extension

Download Full-text

PP7.5 – 1768 Efficacy of long-term adjunctive zonisamide therapy in paediatric patients with partial epilepsy: results of an open-label extension study of a Phase III, randomised, double-blind, placebo-controlled trial

European Journal of Paediatric Neurology ◽

10.1016/s1090-3798(13)70165-x ◽

2013 ◽

Vol 17 ◽

pp. S49 ◽

Cited By ~ 1

Author(s):

A Rosati ◽

L Giorgi ◽

K Bradshaw ◽

R Guerrini

Keyword(s):

Controlled Trial ◽

Partial Epilepsy ◽

Phase Iii ◽

Extension Study ◽

Open Label ◽

Double Blind ◽

Double Blind Placebo ◽

Paediatric Patients ◽

Open Label Extension

Download Full-text

Patient‐Reported Outcomes and the Association With Clinical Response in Patients With Active Psoriatic Arthritis Treated With Golimumab: Findings Through 2 Years of a Phase III, Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Trial

Arthritis Care & Research ◽

10.1002/acr.22044 ◽

2013 ◽

Vol 65 (10) ◽

pp. 1666-1673 ◽

Cited By ~ 16

Author(s):

Arthur Kavanaugh ◽

Iain B. McInnes ◽

Gerald G. Krueger ◽

Dafna Gladman ◽

Anna Beutler ◽

...

Keyword(s):

Psoriatic Arthritis ◽

Clinical Response ◽

Patient Reported Outcomes ◽

Controlled Trial ◽

Phase Iii ◽

Double Blind ◽

Double Blind Placebo ◽

Patient Reported

Download Full-text

A pilot double-blind placebo-controlled trial of pioglitazone as adjunctive treatment to risperidone: Effects on aberrant behavior in children with autism

Psychiatry Research ◽

10.1016/j.psychres.2015.07.043 ◽

2015 ◽

Vol 229 (1-2) ◽

pp. 181-187 ◽

Cited By ~ 29

Author(s):

Ali Ghaleiha ◽

Soudeh Mohebbi Rasa ◽

Mohammadali Nikoo ◽

Mehdi Farokhnia ◽

Mohammad-Reza Mohammadi ◽

...

Keyword(s):

Controlled Trial ◽

Children With Autism ◽

Adjunctive Treatment ◽

Aberrant Behavior ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: Sixteen-Week Results From a Phase III Randomized, Double-Blind, Placebo-Controlled Trial in Patients With Prior Inadequate Response to or Intolerance of Tumor Necrosis Factor Inhibitors.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.734268130.793576219 ◽

2020 ◽

Author(s):

Pedro Machado

Keyword(s):

Tumor Necrosis ◽

Axial Spondyloarthritis ◽

Controlled Trial ◽

Phase Iii ◽

Inadequate Response ◽

Tumor Necrosis Factor Inhibitors ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Necrosis Factor

Download Full-text

Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group

JAMA ◽

10.1001/jama.271.23.1836 ◽

1994 ◽

Vol 271 (23) ◽

pp. 1836-1843 ◽

Cited By ~ 136

Author(s):

C. J. Fisher

Keyword(s):

Receptor Antagonist ◽

Controlled Trial ◽

Interleukin 1 ◽

Sepsis Syndrome ◽

Phase Iii ◽

Study Group ◽

Double Blind ◽

Double Blind Placebo ◽

Interleukin 1 Receptor Antagonist ◽

Trial Phase

Download Full-text

A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pegfilgrastim in Patients Receiving First-Line FOLFOX/Bevacizumab or FOLFIRI/Bevacizumab for Locally Advanced or Metastatic Colorectal Cancer: Final Results of the Pegfilgrastim and Anti-VEGF Evaluation Study (PAVES)

Clinical Colorectal Cancer ◽

10.1016/j.clcc.2016.08.008 ◽

2017 ◽

Vol 16 (2) ◽

pp. 103-114.e3 ◽

Cited By ~ 9

Author(s):

Tamás Pinter ◽

Zandra Klippel ◽

Alvydas Cesas ◽

Adina Croitoru ◽

Jochen Decaestecker ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Controlled Trial ◽

Locally Advanced ◽

Evaluation Study ◽

Phase Iii ◽

First Line ◽

Double Blind ◽

Double Blind Placebo ◽

Anti Vegf

Download Full-text

A phase III double-blind placebo-controlled trial of methylnaltrexone (MNTX) for opioid-induced constipation (OIC) in advanced medical illness (AMI)

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.lba8003 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. LBA8003-LBA8003 ◽

Cited By ~ 11

Author(s):

J. Thomas ◽

A. Lipman ◽

N. Slatkin ◽

G. Wilson ◽

M. Moehl ◽

...

Keyword(s):

Controlled Trial ◽

Phase Iii ◽

Medical Illness ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A randomised, double-blind, placebo-controlled trial to evaluate the efficacy and tolerability of olanzapine as adjunctive treatment for anorexia nervosa in touth: a pilot study

http://isrctn.org/> ◽

10.1186/isrctn23032339 ◽

2013 ◽

Author(s):

Wendy Spettigue

Keyword(s):

Anorexia Nervosa ◽

Pilot Study ◽

Controlled Trial ◽

Adjunctive Treatment ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial

Psychopharmacology ◽

10.1007/s00213-012-2796-8 ◽

2012 ◽

Vol 225 (1) ◽

pp. 51-59 ◽

Cited By ~ 62

Author(s):

Mahtab Asadabadi ◽

Mohammad-Reza Mohammadi ◽

Ahmad Ghanizadeh ◽

Amirhossein Modabbernia ◽

Mandana Ashrafi ◽

...

Keyword(s):

Autistic Disorder ◽

Controlled Trial ◽

Adjunctive Treatment ◽

Double Blind ◽

Double Blind Placebo

Download Full-text